| Literature DB >> 30005670 |
Beatriz Vera-Sirera1, Luis Rubio-Martínez2, Leopoldo Forner-Navarro1, Francisco Vera-Sempere3.
Abstract
BACKGROUND: The role of human papillomavirus (HPV) in orthokeratinized odontogenic cysts (OOCs) has rarely been studied. The objective is to describe the clinicopathological findings in a series of OOCs from a Spanish population that were investigated in relation to the possible presence of HPV.Entities:
Keywords: HPV; High- and low-risk; Orthokeratinized odontogenic cyst; Recurrence
Mesh:
Substances:
Year: 2018 PMID: 30005670 PMCID: PMC6043989 DOI: 10.1186/s13005-018-0167-3
Source DB: PubMed Journal: Head Face Med ISSN: 1746-160X Impact factor: 2.151
Fig. 1Distribution of OOC cases by sex and age
Fig. 2Histological image of a cystic lesion corresponding to an OOC (a), showing orthokeratotic keratinization (b) with the presence of a granulosa layer (arrows) (c) (hematoxylin and eosin, 100× and 400×)
Fig. 3Recurrence of an OOC. Panoramic view showing the wall of a cystic lesion with large areas of hyperplastic verrucous growth with central filling by keratin (a), which is highlighted by PAS staining (b). Hyperplastic verrucous growth shows an endophytic and “pushing” well-differentiated pattern (c). Deeper portions showed epithelial nests with mild atypia and basement membrane integrity (d), which in the immunohistochemical analysis demonstrated proliferative cellular activity (Ki67 positivity) not restricted to the basal cell layer (e), as well as diffuse nuclear p53 reactivity (f)
Clinicopathological characteristics and HPV genotyping results
| Case | Age | Gender | Location | Primary/Recurrence | # FFPE | year | HPV 28 | ICa |
|---|---|---|---|---|---|---|---|---|
| 1 | 38 | Female | Mandible | P | 1 | 2007 | negative | 1 |
| 2 | 34 | Female | Maxilla | P | 2 | 2002 | negative | 1 |
| 3 | 39 | Male | Mandible | P | 3 | 2004 | negative | 3 |
| 4 | 37 | Female | Mandible | P | 1 | 2006 | negative | 1 |
| 5 | 18 | Female | Mandible | P | 1 | 2007 | ND | 0 |
| 6 | 42 | Male | Mandible | P | 2 | 2006 | negative | 2 |
| 7 | 25 | Male | Mandible | P | 1 | 2007 | ND | 0 |
| 8 | 36 | Female | Mandible | P | 1 | 2011 | negative | 1 |
| 9 | 38 | Male | Mandible | P | 2 | 2006 | negative | 2 |
| 10 | 19 | Male | Mandible | P | 6 | 2001 | negative | 5 |
| 11 | 35 | Male | Mandible | P | 2 | 2014 | negative | 2 |
| 12 | 45 | Male | Mandible | P | 2 | 2014 | negative | 2 |
| 13 | 14 | Male | Mandible | P&R | 4 & 5 | 2015 / 2016 | negative | 4 & 5 |
| 14 | 39 | Male | Mandible | P | 1 | 2016 | negative | 1 |
| 14 | 45 | Male | Mandible | P | 3 | 2014 | negative | 2 |
| 16 | 65 | Male | Maxilla | P | 1 | 2013 | negative | 1 |
ICa: DNA Internal Control (number of the FFPE bloks showing a positive beta-globin gene amplification)